Associate Director, Biologics Process Analytics (Hybrid)

Scorpion Therapeutics; Pennsylvania; Hybrid; USD 150,000 - 230,000; Full time

Benefits offered by this job

Hybrid work arrangement

Travel up to 15%

Job summary

Scorpion Therapeutics seeks an Associate Director of Advanced Process Analytics & Data Strategy to apply data science, process modeling, and data architecture to optimize biologics production. The role collaborates with manufacturing, IT, and quality teams and reports to senior management.

Responsibilities include defining analytics roadmaps, leading cross-functional data initiatives, and building manufacturing data systems. Hybrid work with up to 15% travel is expected.

Qualifications

• B.S. in Chemical/Biochemical Engineering or related field with 8+ years bioprocess experience.
• M.S. with 6+ years or Ph.D. with 4+ years in bioprocessing preferred.
• Expertise in biologics manufacturing (upstream/downstream) and GMP compliance.
• Strong Python, R, SQL and data-architecture skills.

Responsibilities

• Define analytics roadmaps connecting process parameters and quality attributes.
• Lead cross-functional data initiatives.
• Build and maintain manufacturing data architecture.
• Develop process monitoring tools supporting PPM and CPV.

Skills

Python

R

SQL

Data architecture

Biologics manufacturing

Education

B.S. in Chemical/Biochemical Engineering or related field

M.S. in Chemical/Biochemical Engineering or related field

Ph.D. in Chemical/Biochemical Engineering or related field

Tools

PI, MES, LIMS

OSIsoft PI

Seeq

Power BI

GMP analytics (PPM, CPV)

Job description

Scorpion Therapeutics seeks an Associate Director of Advanced Process Analytics & Data Strategy to apply data science, process modeling, and data architecture to optimize biologics production. The role collaborates with manufacturing, IT, and quality teams and reports to senior management.

Responsibilities include defining analytics roadmaps, leading cross-functional data initiatives, and building manufacturing data systems. Hybrid work with up to 15% travel is expected.